| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.07B | $3.77B | $3.65B |
| YoY Revenue Growth % | +7.8% | +3.3% | — |
| Gross Profit | $1.84B | $1.67B | — |
| Gross Margin % | 45.2% | 44.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $859.5M | $780.7M | $708.4M |
| Operating Margin % | 21.1% | 20.7% | 19.4% |
| Net Income (GAAP) | $643.8M | $597.5M | $540.6M |
| EBITDA (Normalized) | $1.01B | $854.4M | $839.8M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $783.8M | $675.0M | $600.6M |
| Capital Expenditures (CapEx) | $183.0M | $92.1M | $164.3M |
| Free Cash Flow (FCF) | $600.8M | $582.9M | $436.3M |
| FCF Margin % | 14.8% | 15.5% | 12.0% |
| Return on Invested Capital (ROIC %) | 18.4% | 20.7% | 10.7% |
| Cash & Short-Term Equivalents | $356.2M | $503.8M | — |
| Total Debt (Short + Long Term) | $1.98B | $1.98B | $2.03B |
| Total Stockholders' Equity | $2.07B | $1.50B | $4.16B |